Lonza Announces Collaboration with Roslin Cells for Pluripotent Stem Cell Media Development

06-Aug-2010 - USA

Lonza Walkersville, Inc. (US) has entered a worldwide, in kind research collaboration agreement with Roslin Cells for the development of customized cell culture media and processes for the production of pluripotent stem cells (PSCs) to advance the field of cell therapy.

This collaborative research arrangement combines Roslin Cells’ expertise in developing cGMP grade pluripotent stem cells with Lonza’s expertise in primary cell media formulation. It will allow the companies to share technologies, know how, and other intellectual property in order to accelerate the development of industry leading PSC culture media and systems for use in both research and clinical applications.

The main purpose of this collaboration is to provide those involved in both regenerative medicine research and in the production of clinical cell-based products with high-quality, scalable, culture systems that meet the stringent regulations that govern cellular therapies.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

View topic world
Topic world Cell culture technology

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.